Avalon Globocare Corp.
Freehold, New Jersey, United States · Artificial Intelligence, Biotechnology, Healthcare
Avalon GloboCare Corp. (NASDAQ: ALBT) is a commercial stage company dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role in the innovation of diagnostic testing, utilizing proprietary technology to deliver precise, genetics-driven results. The Company also provides laboratory services, off
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Freehold, New Jersey, United States
- Employees
- Unknown
- Industries
- Artificial Intelligence, Biotechnology, Healthcare
- Status
- Public (CHGA)
- Website
- avalon-globocare.com
Recent activity at Avalon Globocare Corp.
- : SEC 8-K (1.01): On September 30, 2026, Change Agents Corporation entered into a material definitive agreement by issuing promissory notes to accredited investors totaling $336,000, which includes a $36,000 original issuance discount. The company generated gross proceeds of $300,000, which were utilized to repay prior debts: $125,000 towards 18.75% notes from June 2025, another $125,000 to redeem Series F Preferred Stock, and $37,125 toward a payment under a July 2026 Business Loan and Security Agreement. This financing arrangement is intended to facilitate working capital and general corporate purposes, bolstering the company’s financial stability.
- : Change Agents Corporation Secures $125,000 in Funding from AWS
- : SEC 8-K (8.01): On August 31, 2026, Change Agents Corporation announced the completion of a collaboration project with Amazon Web Services (AWS) for its catch-up agentic AI video platform, officially signaling the end of Phase 2 development. As per the agreement, AWS provided funding of $125,000, contingent upon the project's timely completion within 7 months. This collaboration was initially reported on April 21, 2026, and marks a significant milestone in advancing the company's AI capabilities. The completion of this project not only secures the funding but also strengthens the strategic partnership between Change Agents and AWS, potentially enhancing the company's market position in AI video technology.
About Avalon Globocare Corp.: questions and answers
What does Avalon Globocare Corp. do?
Avalon GloboCare Corp. (NASDAQ: ALBT) is a commercial stage company dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role in the innovation of diagnostic testing, utilizing proprietary technology to deliver precise, genetics-driven results. The Company also provides laboratory services, off
Where is Avalon Globocare Corp. headquartered?
Avalon Globocare Corp. is headquartered in Freehold, New Jersey, United States.
What is the latest news on Avalon Globocare Corp.?
On Sep 28, 2026, SEC 8-K (1.01): On September 30, 2026, Change Agents Corporation entered into a material definitive agreement by issuing promissory notes to accredited investors totaling $336,000, which includes a $36,000 original issuance discount. The company generated gross proceeds of $300,000, which were utili
Is Avalon Globocare Corp. a public company?
Yes. Avalon Globocare Corp. is publicly traded under the ticker CHGA.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy